Memphasys lands first sale of breakthrough IVF tech
In a milestone achievement, Memphasys has landed the first sale of the company’s revolutionary trademarked Felix…
Memphasys hits the mark with horse fertility tests
Reproductive biotechnology company Memphasys looks to be hitting the mark in the high value world of horse breeding…
Memphasys achieves critical accreditation for key markets
Trailblazing biotech Memphasys Ltd has achieved a crucial step in the rollout of its IVF sperm separation technology…
Memphasys notches up more sales of its IVF technology
Australian-based biotechnology venture Memphasys Limited has sold off more units of its sperm separation system known…
Could this be a game changer for unsuccessful IVF couples?
Listen to ASX-listed Memphasys Executive Chair Alison Coutts talk to Matt Birney on the Bulls N’ Bears Report about…
Memphasys and Hydrix win Gold!
The Felix™ device has received a Gold Good Design Award for engineering design and a Good Design Award for product…
Professor John Aitken – Felix™ System Interview
Professor John Aitken, PhD, ScD, FRSE, formerly School of Environmental and Life Sciences (Biological Sciences),…
Operational Update
Commercial sales for Felix device into initial markets anticipated to commence mid to late CY2020